Full Description
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
Contains 13 relevant, practice-oriented topics including optimal medical therapy for stable ischemic heart disease in 2024: focus on antithrombotic therapy; antiplatelet therapy for patients that have undergone revascularization within the past year: which agents and for how long; ischemic heart disease in women: focus on SCAD and MINOCA; and more.
Provides in-depth clinical reviews on patient management with stable ischemic heart disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Contents
The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease
Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
When to Consider Coronary Revascularization for Stable Coronary Artery Disease
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
Ischemic Heart Disease in Women
Chronic Coronary Disease in Older Adults
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
